Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population

Tumor Biology

Volumn 37, Issue 4, 2016, Pages 5467-5473

  Yin, Jiaoyang ^a   Wang, Huiwen ^a   Vogel, Ulla ^b   Wang, Chunhong ^a   Hou, Wei ^c   Ma, Yegang ^d  

^a SHENYANG MEDICAL COLLEGE   (China)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Chinese; Interaction; Lung cancer; NFKB1 rs28362491 and PPP1R13L and CD3EAP; Single nucleotide polymorphisms

Indexed keywords

ADENINE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GUANINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN CD3EAP; PROTEIN NFKB1; PROTEIN PPP1R13L; THYMINE; UNCLASSIFIED DRUG; CD3EAP PROTEIN, HUMAN; NFKB1 PROTEIN, HUMAN; PPP1R13L PROTEIN, HUMAN; REPRESSOR PROTEIN; SIGNAL PEPTIDE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTIFACTOR DIMENSIONALITY REDUCTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ADVERSE EFFECTS; CARCINOGENESIS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; INDEL MUTATION; LUNG TUMOR; RISK FACTOR;

CARCINOGENESIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDEL MUTATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; RISK FACTORS; SMOKING;

EID: 84946949546     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4373-3     Document Type: Article

References (29)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
2. Chen Z. Medical genetics. 1st ed. Beijing: People Hygienic Press; 2001. p. 262–3.
3. Sun XF, Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol. 2007;22:1387–98.
4. Andersen V, Christensen J, Overvad K, Tjønneland A, Vogel U. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer. 2010;10:484.
5. Kopp TI, Andersen V, Tjønneland A, Vogel U. Polymorphisms in NFKB1 and TLR4 and interaction with dietary and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study. PLoS One. 2015;10:e0116394.
6. Kopp TI, Friis S, Christensen J, Tjønneland A, Vogel U. Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men. Cancer Genet. 2013;206:266–78.
7. Zhou B, Qie M, Wang Y, Yan L, Zhang Z, Liang A, et al. Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol. 2010;21:506–11.
8. Cai H, Sun L, Cui L, Cao Q, Qin C, Zhang G, et al. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma. Urol Int. 2013;91:206–12.
9. Li P, Gu J, Yang X, Cai H, Tao J, Yang X, et al. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population. PLoS One. 2013;8:e71604.
10. Wang Z, Liu QL, Sun W, Yang CJ, Tang L, Zhang X, et al. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk. Croat Med. 2014;55:638–46.
11. Hua T, Qinsheng W, Xuxia W, Shuguang Z, Ming Q, Zhenxiong L, et al. Nuclear factor-kappa B1 is associated with gastric cancer in a Chinese population. Medicine (Baltimore). 2014;93:e279.
12. Gao J, Xu HL, Gao S, Zhang W, Tan YT, Rothman N, et al. Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case–control study in Shanghai, China. BMJ Open. 2014;4:e004427.
13. Wang Y, Chen L, Pan L, Xue J, Yu H. The association between NFKB1-94ins/del ATTG polymorphism and non-small cell lung cancer risk in a Chinese Han population. Int J Clin Exp Med. 2015;8:8153–7.
14. Chen LP, Cai PS, Liang HB. Association of the genetic polymorphisms of NFKB1 with susceptibility to ovarian cancer. Genet Mol Res. 2015;14:8273–82.
15. Zhang Q, Ji XW, Hou XM, Lu FM, Du Y, Yin JH, et al. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma. Ann Oncol. 2014;25:2413–9.
16. Arisawa T, Tahara T, Shiroeda H, Yamada K, Nomura T, Yamada H, et al. Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer. Oncol Rep. 2013;30:3013–9.
17. Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, et al. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013;37:634–8.
18. Pallavi S, Anoop K, Showket H, Alo N, Mausumi B. NFKB1/NFKBIa polymorphisms are associated with the progression of cervical carcinoma in HPV-infected postmenopausal women from rural area. Tumour Biol. 2015;36:6265–76.
19. Vangsted AJ, Klausen TW, Gimsing P, Abildgaard N, Andersen NF, Gregersen H, et al. The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP. Ann Hematol. 2011;90:675–84.
20. Simpson MA, Cook RW, Solanki P, Patton MA, Dennis JA, Crosby AH. A mutation in NFkappaB interacting protein 1 causes cardiomyopathy and woolly haircoat syndrome of Poll Hereford cattle. Anim Genet. 2008;40:42–6.
21. Yin J, Vogel U, Ma Y, Wang H, Wang C, Liang D, et al. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population. Lung Cancer. 2012;76:286–91.
22. Yin J, Vogel U, Wang H, Ma Y, Wang C, Liang D, et al. HapMap-based study identifies risk sub-region on chromosome 19q13.3 in relation to lung cancer among Chinese. Cancer Epidemiol. 2013;37:923–9.
23. Vogel U, Laros I, Jacobsen NR, Thomsen BL, Bak H, Olsen A, et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res. 2004;546:65–74.
24. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928–9.
25. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69:138–47.
26. Vangsted AJ, Klausen TW, Gimsing P, Andersen NF, Abildgaard N, Gregersen H, et al. A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support. Haematologica. 2009;94:1274–81.
27. Dzhugashvili M, Luengo-Gil G, García T, González-Conejero R, Conesa-Zamora P, Escolar PP, et al. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2014;90:595–602.
28. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004;13:35–45.
29. Yin J, Yin M, Vogel U, Wu Y, Yao T, Cheng Y, et al. NFKB1 common variants and PPP1R13L and CD3EAP in relation to lung cancer risk in a Chinese population. Gene. 2015;567:31–5.